Adjuvants - OmicsDI

Show results for

Unknown (3180)
Genomics (191)
Transcriptomics (148)
Proteomics (28)
Other (4)
Metabolomics (4)
Clinical (2)

Organisms

Mus musculus (95)
Homo sapiens (40)
Macaca mulatta (13)
Influenza B virus (10)
Influenza A virus (10)
Gallus gallus (6)
Staphylococcus aureus (4)
Rattus norvegicus (3)
Ovis aries (2)
Primates (2)
Macaca fascicularis (2)
Oryctolagus cuniculus (1)
Burkholderia cenocepacia (1)
Betapolyomavirus macacae (1)
human gammaherpesvirus 4 (1)
JC polyomavirus (1)
Betapolyomavirus hominis (1)
Human alphaherpesvirus 1 (1)
Sus scrofa domesticus (1)
Human gammaherpesvirus 8 (1)
Murid gammaherpesvirus 4 (1)
Murid betaherpesvirus 1 (1)
Human immunodeficiency virus 1 (1)
Human betaherpesvirus 5 (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Canis lupus familiaris (1)
Scophthalmus maximus (1)
Pseudomonas aeruginosa (1)
Escherichia coli (1)
Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504 = JCM 12093 (1)

Organisms

Mus musculus (74)
Homo sapiens (35)
Macaca mulatta (14)
Staphylococcus aureus (4)
Escherichia coli (2)
Pseudomonas aeruginosa (2)
Gallus gallus (2)
Escherichia coli str. K-12 substr. MG1655 (1)
Scophthalmus maximus (1)
Macaca fascicularis (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Ovis aries (1)
Canis lupus familiaris (1)
mouse metagenome (1)
Rattus norvegicus (1)
Sus scrofa domesticus (1)

Repository

ENA (185)
geo (123)
biostudies-arrayexpress (45)
pride (14)
MetaboLights (4)
MassIVE (3)
EGA (1)
iProX (1)

Tissue

Blood (2)
Blood cell (2)
Cell culture (2)
Blood serum (1)
Dendritic cell (1)
Epithelial cell (1)
Macrophage (1)
T cell (1)

Disease

T-cell acute lymphoblastic leukemia (1)
Cataract (1)
Colorectal Neoplasms (1)
Allergy (1)
Disease free (1)
Pollen allergy (1)

Technology Type

Mass Spectrometry (14)
Shotgun proteomics (7)
Bottom-up proteomics (4)
Mass spectrometry assay (2)
Mass spectrometry (2)
Data-independent acquisition (2)
SWATH MS (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Data-dependent acquisition (1)
Immunopeptidomics (1)

Instrument Platform

NextSeq 500 (3)
Illumina HiSeq 2500 (2)
Q Exactive (2)
Liquid Chromatography MS - negative - reverse phase (2)
NextSeq 550 (1)
Illumina NovaSeq 6000 (1)
TripleTOF 5600 (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)

Publication Date

2025 (29)
2026 (25)
2022 (19)
2024 (15)
2023 (12)
2010 (11)
2013 (10)
2020 (9)
2021 (8)
2017 (7)
2014 (7)
2009 (7)
2012 (6)
2016 (5)
2011 (5)
2019 (5)
2018 (4)
2015 (3)
2008 (1)
2007 (1)
2005 (1)

CHEBI ID

CHEBI:57429 (1)
CHEBI:80961 (1)
CHEBI:58115 (1)
CHEBI:60377 (1)
CHEBI:45394 (1)
CHEBI:40154 (1)
CHEBI:60761 (1)
CHEBI:18077 (1)
CHEBI:15713 (1)
CHEBI:17202 (1)
CHEBI:17677 (1)
CHEBI:16695 (1)
CHEBI:16742 (1)
CHEBI:40101 (1)
CHEBI:2129 (1)
CHEBI:15996 (1)
CHEBI:15422 (1)
CHEBI:16027 (1)
CHEBI:16761 (1)
CHEBI:30769 (1)

Metabolite Name

UTP_C13 (1)
FUTP (1)
5FUMP (1)
FdUMP (1)
FUrd (1)
5FU (1)
Citric acid-1,5-13C2 (1)
(2S,3R)-3-hydroxybutane-1,2,3-tricarboxylate (1)
PE(16:0_9:0COOH) (1)
PE(16:0_19:2COOH) (1)
PE(16:0_19:1CHO) (1)
PE(16:0_19:1) (1)
PE(16:0_18:0CHO) (1)
PE(16:0_18:0) (1)
PE(16:0_17:0) (1)
PE(16:0_16:1CHO) (1)
PE(16:0_16:0CHO) (1)
PE(16:0_14:1) (1)
PE(16:0COOH_18:1) (1)
PE(15:1_17:1) (1)
PE(15:0_19:2COOH) (1)
PE(15:0_17:1) (1)
PE(15:0_16:1) (1)
PE(15:0_16:0) (1)
PE(14:1_17:1) (1)
PE(14:0_19:1CHO) (1)
PE(14:0_18:0CHO) (1)
PE(14:0_17:2COOH) (1)
PE(14:0_17:1) (1)
PE(14:0_16:1) (1)

First Public Date

2025 (37)
2026 (27)
2024 (19)
2014 (19)
2022 (18)
2023 (17)
2020 (14)
2021 (13)
2019 (9)
2017 (6)
2018 (4)
2015 (1)
2013 (1)

Classification

bacteria (9)
viruses (1)

Study status

Recruiting (2)

Study type

Transcription profiling by array (36)
RNA-seq of coding RNA (5)
RNA-seq of coding RNA from single cells (2)
DNA-seq (1)
Observational patient registry (1)
Interventional (1)

Release Date

2022 (407)
2023 (377)
2021 (318)
2025 (312)
2024 (295)
2020 (283)
2018 (198)
2019 (194)
2017 (166)
2016 (128)
2014 (115)
2015 (110)
2013 (69)
2012 (57)
2010 (46)
2011 (43)
2026 (38)
2009 (26)
2008 (14)
2007 (8)
2006 (8)
2002 (3)
2005 (2)
2004 (2)
2003 (1)
2001 (1)
2000 (1)
1999 (1)
1998 (1)
1997 (1)

Lab affiliation

Boston Children's Hospital and Harvard Medical School (1)
Department of Chemical Sciences, University of Naples “Federico II”, Naples, Italy. (1)
Department of Chemistry and Bioscience, Aalborg University, Fredrik Bajers Vej 7H, DK-9220, Aalborg East, Denmark (1)
Department of Infection Biology Institute of Infection and Global Health University of Liverpool (1)
Department of Medical Informatics and Statistics, BK21 Project, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (1)
Department of Pharmacology, University of Oxford, United Kingdom (1)
Interfaculty Institute for Cell Biology Department of Immunology University of Tübingen Auf der Morgenstelle 15 72076 Tübingen Germany (1)
MS Omics, Biohub Chicago, USA (1)
Medical University of South Carolina College of Medicine Department of Microbiology and Immunology Acting Associate Professor, Department of Surgery, Department of Microbiology and Immunology Emory University School of Medicine Director Translational Research for Cutaneous Malignancies Winship Cancer Institute of Emory University (1)
NICM Health Research Institute, Western Sydney University (1)
Proteomics Center, Erasmus MC (1)
SaBio. Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ronda de Toledo s/n, 13005 Ciudad Real, Spain. (1)
UCL (1)
University of Salzburg, Department of Molecular Biology, Division of Chemistry and Bioanalytics, Hellbrunnerstraße 34, 5020 Salzburg, Austria (1)

Location

South Korea (1)
United States (1)
Australia (1)

Keyword

Neglected Diseases (1)
Orphan Diseases (1)
Rare Disease Research (1)
Registries (1)
Batten Disease (1)
Mucolipidosis IV (1)
Undiagnosed (1)
Uncommon Disease (1)
Hypersomnia (1)
Marinesco-Sjogren Syndrome (1)
4p-/Wolf-Hirschhorn Syndrome (1)
Wiedermann-Steiner Syndrome (1)
Hemophagocytic Lymphohistiocytosis (HLH) (1)
Behcet’s Disease (1)
Jansen metaphyseal chondrodysplasia (1)
Chronic recurrent multifocal osteomyelitis (CRMO) (1)
Hereditary Sensory and Autonomic Neuropathy (1)
Nephropathic infantile cystinosis (1)
Ocular cystinosis (1)
Spinal Bulbar Muscular Atrophy (SBMA) (1)
Mucolipidosis (1)
Mitochondrial aminoacyl-tRNA synthetases (Mt-aaRS Disorders) (1)
Shine Syndrome (1)
Intestinal Bromhidrosis Syndrome (1)
Autosomal recessive extra oral halitosis (1)
CACNA1H mutation (1)
Dimethylglycine dehydrogenase deficiency (1)
Morphine (1)
Dexmedetomidine (1)
Lidocaine (1)

Previous page
1 / 356
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 356
Next page

Sort by:

Relevance

Page size

Nano-formulated bisphosphonate adjuvants simultaneously induce humoral and cellular immunity

Adjuvant is an important component of vaccines However, given the limitation of existing adjuvants in variety and mechanism, developing a unique and effective adjuvant is urgently needed for clinal applications. Recent studies have implicated that the mevalonate pathway plays an essential role in va...

2026-03-03 | MTBLS11696 | MetaboLights

Transcription profiling of mouse peritoneal exudate cells after treatment with selected adjuvants

The effect of selected adjuvants on the mRNA expression of peritoneal exudate cells.

ORGANISM(S): Mus musculus

2009-09-23 | E-MEXP-1814 | biostudies-arrayexpress

Transcription profiling of mouse muscle tissue after in-vivo intramuscularly administration of MF59, CpG, MF59+CpG, alum and PBS

Analysis of whole mouse muscle gene expression signature induced by in-vivo intramuscularly administration of MF59, CpG, MF59+CpG, alum and PBS. MF59 and alum are licensed human vaccine adjuvants; CpG is a TLR-agonist adjuvant.

ORGANISM(S): Mus musculus

2009-07-03 | E-TABM-506 | biostudies-arrayexpress

Expression data from murine vaginal samples following adjuvant treatment

Vaccine research today is focused on using safer, highly purified or recombinant antigens with poor immunogenicity, which has created a need for potent adjuvants. Rational design of effective and safe mucosal adjuvants for human use necessitates a thorough understanding of the mode of action of succ...

ORGANISM(S): Mus musculus

2011-12-30 | E-GEOD-27149 | biostudies-arrayexpress

Characterizing adjuvants’ effects at the murine immunoglobulin repertoire level

PRJNA951738 | ENA

Transcriptomic signatures induced by single versus dual lipoparticle-formulated adjuvants

PRJNA1509018 | ENA

studys on adjuvants

PRJNA857815 | ENA

Molecular signatures of clinically tested vaccine adjuvants

Differential gene expression in mouse whole blood and lymph nodes at 4 different timepoints following administration of different vaccine/adjuvants combinations

ORGANISM(S): Mus musculus

2017-01-09 | GSE85339 | GEO

Comparative tissue proteomics reveals unique action mechanisms of vaccine adjuvants

This proteomics data are generated from mouse skin treated with physical radiofrequency adjuvant and common chemical adjuvants, such as AddaVax, MPL, Alum, MPL/Alum.

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

2022-11-09 | MSV000090681 | MassIVE

Mus musculus

Molecular signatures of clinically tested vaccine adjuvants

PRJNA338195 | ENA

Previous page
1 / 356
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 356
Next page

Sort by:

Relevance

Page size

3558 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets